Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Pancreatitis
Studies from Meiji Seika Kaisha, Ltd. add new findings in the area of acute pancreatitis
May 4th, 2008
"It is known that prophylaxis with imipenem reduces the risk of infection accompanying severe acute pancreatitis. In this study, we modified a rat experimental model of severe acute pancreatitis for antibiotic evaluation, and the effect of biapenem was compared with that of imipenem to determine the usefulness of biapenem," scientists writing in the journal Pancreas report. "Severe acute pancreatitis was induced by 5% sodium taurocholate. Antibiotics were subcutaneously administered at 3 and 6 hours and evaluated at 12 hours after the pancreatitis induction. For pharmacokinetic evaluation, antibiotics were subcutaneously administered at 3 hours after the...
Source: Pharma Investments, Ventures & Law Weekly (2008-05-04)
|
